Real-world comparative effectiveness of first-line Bruton tyrosine kinase inhibitors (BTKis) in patients with chronic lymphocytic leukemia (CLL).

Authors: Ryan Jacobs, Xiaoliang Wang, Qianhong Fu, Dong Yuan, Derrick van Beuge, Gregory A. Maglinte, Erlene Kuizon Seymour, Mazyar Shadman

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23264

Source: Full article

---

Abstract

e23264